The market for microtome is anticipated to gain growth at a significant CAGR during the forecast period. The increasing number of healthcare facilities, the growing use of portable sleep apnea devices, and the rising acceptance of sensors and wearable monitors are all propelling the market forward.

Apart from that, the increasing prevalence of obstructive sleep apnea (OSA) and insomnia, as well as the growing global senior population, are propelling the growth of the global sleeping pills market.  According to American Sleep Association, every year, approximately 50 million Americans are diagnosed with one of 80 distinct sleep disorders. Furthermore, it was discovered that 20 to 30 million people in the US suffer from intermittent sleep disorders yearly. Insomnia is the most common sleep disorder, according to the ASA, with nearly 30% of adults in the US suffers from short-term troubles and around 10% reporting chronic insomnia. The increased occurrence of these illnesses is accelerating the market's growth.

In addition to that, different lifestyle changes in people, such as increased caffeine, tobacco, and alcohol consumption, are driving the market forward. Furthermore, increasing working hours, a high workload and job pressure, and a stressful work atmosphere all contribute to increased stress and poor sleep quality. As a result, sales of over the counter (OTC) sleeping medicines, which help to improve sleep quality, are increasing globally.

Market Coverage 

    • The market number available for – 2021-2027

    • The base year – 2020 

    • The forecast period is from 2021 to 2027 

    • Segment Covered- 

o By Medication

o By Sleep disorder

    • Regions Covered 

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape: Koninklijke Philips N.V., Merck & Co., Sanofi, eVilbiss Healthcare LLC., Pfizer Inc., SleepMed Inc., Cadwell Laboratories Inc., GlaxoSmithKline plc

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Sleeping Pills Market by Segments 

By Medication

    • Prescription-based Drugs

    • OTC drugs

    • Herbal drugs

By Sleep Disorder

    • Insomnia

    • Sleep Apnea

    • Restless Legs Syndrome

    • Narcolepsy

    • Sleep Walking

    • Other Sleep Disorders

Global Sleeping pill market by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific

Rest of the World

    • Latin America 

    • Middle East & Africa